Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Cutan Pathol ; 47(6): 554-560, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31995237

ABSTRACT

Liposarcomas are categorized into four distinct histopathological subtypes: atypical lipomatous tumors (ALT)/well-differentiated liposarcoma (WDL), dedifferentiated, myxoid, and pleomorphic. Dedifferentiated liposarcomas account for approximately 18% of all liposarcomas, characteristically arising in the deep soft tissue. They are reported to have lower rates of metastasis compared to other pleomorphic sarcomas.1 -3 The classic histopathologic appearance is ALT/WDL admixed or juxtaposed with a predominantly nonlipogenic sarcoma. Epithelioid features are rare, appearing in as few as 3% of tumors, and have not previously been reported in a superficial location. Herein, we present a 57-year-old male with intradermal and subcutaneous metastasis of his known deep dedifferentiated liposarcoma with epithelioid features. By H&E the tumor featured cords and sheets of crowded, plump, epithelioid cells with thick nuclear membranes and prominent nucleoli, which raised a broad differential including carcinoma and melanoma. By immunohistochemistry the tumor was diffusely positive for MDM2 and CDK4, on the other hand stains for Sox10, Melan A, MITF, CKAE1/3, desmin, and S100 protein were negative. This case serves as an opportunity to raise awareness of this rare morphological subtype, which can involve the skin and mimic epithelial and melanocytic malignancies. It can be a potential diagnostic pitfall, especially if metastases are the first presentation.


Subject(s)
Epithelioid Cells/pathology , Liposarcoma/metabolism , Skin Neoplasms/pathology , Soft Tissue Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Cyclin-Dependent Kinase 4/metabolism , Diagnosis, Differential , Doxorubicin/therapeutic use , Fatal Outcome , Female , Humans , Immunohistochemistry/methods , Liposarcoma/diagnosis , Liposarcoma/drug therapy , Liposarcoma/surgery , Lost to Follow-Up , Male , Middle Aged , Neoplasm Metastasis/pathology , Proto-Oncogene Proteins c-mdm2/metabolism , Subcutaneous Tissue/pathology , Topoisomerase II Inhibitors/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL